Onebright expands neurodevelopmental offering with Psicon acquisition

Rising demand for support among neurodivergent population

Jaskeet Briah
clock • 2 min read

Private outpatient mental healthcare company, Onebright, has expanded its neurodevelopmental services with the acquisition of Psicon, for an undisclosed sum.

Psicon is a provider of neurodevelopmental assessments for autism and ADHD, offering private assessments to the public and working "extensively" with the NHS, Onebright detailed. The provider offers a range of assessment and treatment services across the lifespan, Onebright noted, and is one of the largest providers of children's neurodevelopmental services in the UK. Dr Dan Simmonds, managing director of Psicon, said: "Demand for high-quality support for the neurodivergent population has increased substantially up and down the country and we look forward to working within the Onebrig...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Individual Protection

NHS waiting list drops to 7.29m

NHS waiting list drops to 7.29m

Average wait time increased to 13.4 weeks

Jaskeet Briah
clock 12 February 2026 • 2 min read
Only a third of men would tell their partner about cancer diagnosis

Only a third of men would tell their partner about cancer diagnosis

Bupa research findings

Jaskeet Briah
clock 12 February 2026 • 2 min read
Half of couples unsure on location of their partner's will

Half of couples unsure on location of their partner's will

40% know where to find life insurance policy

Jaskeet Briah
clock 04 February 2026 • 2 min read